Skip to main content
58°
Rain
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Innate Pharma Shares Efficacy and Safety Phase 1 /2 Results of NK Cell Engager SAR443579 / IPH6101 Developed by Sanofi at ASH 2023
Today 1:00 EST
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Ferring and PharmaBiome Enter Into a New Microbiome R&D Collaboration and Exclusive Licensing Agreement
Today 1:00 EST
From
Ferring Pharmaceuticals
Via
Business Wire
KuCoin Labs Invests in Dovi, a Bitcoin L2 Solution, to Further Advance the Development of BTC Ecosystem
Today 1:00 EST
From
KuCoin
Via
Business Wire
ASE Technology Holding Co., Ltd Receives Industry Leadership Recognition on the Dow Jones Sustainability Indices for the Eighth Year in a Row
December 10, 2023
From
ASE Technology Holding Co., Ltd.
Via
Business Wire
Tickers
ASX
Bristol Myers Squibb Presents New Data at ASH 2023 Demonstrating Clinical Benefit Across B-cell Malignancies with Breyanzi as a Second-Line Treatment in High-Risk Follicular Lymphoma and in Relapsed or Refractory Chronic Lymphocytic Leukemia
December 10, 2023
From
Bristol Myers Squibb
Via
Business Wire
Tickers
BMY
Mitsubishi Electric and TXOne Networks to Cooperate in Mutual Expansion of OT Security Businesses
December 10, 2023
From
Mitsubishi Electric Corporation
Via
Business Wire
Boosting Business Acumen: Chicago Booth’s Executive Education Program in Finance Workshop for Non-Financial Leaders–Available in Hong Kong and Chicago
December 10, 2023
From
Chicago Booth Executive Education
Via
Business Wire
New Operation HOPE Research Finds That Financial Literacy Resources, Tools & Coaching Services Are Key Drivers of Optimism Despite Uncertain Economic Times
December 10, 2023
From
Operation HOPE, Inc.
Via
Business Wire
Long-term ALPHA Phase III trial data showed danicopan as add-on to ULTOMIRIS® or SOLIRIS® sustained clinical improvements in subset of patients with PNH experiencing clinically significant extravascular hemolysis
December 10, 2023
From
Alexion
Via
Business Wire
Tickers
AZN
MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study
December 10, 2023
From
MorphoSys AG
Via
Business Wire
Tickers
MOR
New Data for Genentech’s Columvi and Lunsumio Presented at ASH 2023 Support Continued Benefit for People With Lymphoma
December 10, 2023
From
Genentech
Via
Business Wire
Tickers
RHHBY
ADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy Combination Delivers 100% Progression Free Survival at 12 months in Phase 2 Trial of Patients with Early Stage Classical Hodgkin Lymphoma
December 10, 2023
From
Seagen Inc.
Via
Business Wire
Tickers
SGEN
Latest Data of InnoCare’s Oncology Pipelines Presented at the 65th Annual Meeting of ASH
December 10, 2023
From
InnoCare Pharma
Via
Business Wire
Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Durable Responses in Chronic Graft-Versus-Host Disease
December 10, 2023
From
Incyte and Syndax Pharmaceuticals
Via
Business Wire
Tickers
INCY
SNDX
Morrow Sodali Acquires Australian Corporate Communication Consultancy, Domestique
December 10, 2023
From
Morrow Sodali
Via
Business Wire
Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of Hemophilia B
December 10, 2023
From
Be Biopharma, Inc.
Via
Business Wire
Long-Term Data Presented at ASH Support beti-cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independence and Normal or Near-Normal Adult Hb Levels
December 10, 2023
From
bluebird bio, Inc.
Via
Business Wire
Tickers
BLUE
Adicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual Meeting
December 10, 2023
From
Adicet Bio, Inc.
Via
Business Wire
Tickers
ACET
Schrödinger Presents Data Supporting Advancement of SGR-1505 and SGR-2921 at American Society of Hematology 2023 Annual Meeting
December 10, 2023
From
Schrödinger
Via
Business Wire
Tickers
SDGR
NKLA DEADLINE TUESDAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Nikola Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – NKLA
December 10, 2023
From
The Rosen Law Firm, P.A.
Via
Business Wire
Tickers
NKLA
GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia
December 10, 2023
From
GlycoMimetics, Inc.
Via
Business Wire
Tickers
GLYC
ImmunoGen Presents Findings from Newly Diagnosed Acute Myeloid Leukemia Cohorts in Phase 1b/2 Study of Pivekimab Sunirine in Combination with Azacitidine and Venetoclax at ASH
December 10, 2023
From
ImmunoGen Inc.
Via
Business Wire
Tickers
IMGN
Teoayeah’s Christmas Gift List for All Kids (12/11-12/24)
December 10, 2023
From
Teoayeah
Via
Business Wire
Innate Pharma Presents Positive Results From TELLOMAK Phase 2 Study With Lacutamab in Patients With Sézary Syndrome at ASH 2023
December 10, 2023
From
Innate Pharma SA
Via
Business Wire
Tickers
IPHA
Belgian, Port Houston and Partners Sign Memorandum of Understanding on Energy Transition Cooperation
December 09, 2023
From
Port Houston
Via
Business Wire
Marstacimab Phase 3 Data Presented at ASH 2023 Demonstrate Significant Bleed Reduction in Hemophilia A and B
December 09, 2023
From
Pfizer Inc.
Via
Business Wire
Tickers
PFE
Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual Meeting
December 09, 2023
From
Orca Bio
Via
Business Wire
Bristol Myers Squibb Presents Primary Efficacy and Safety Analysis of the Phase 3 COMMANDS Trial of Reblozyl for Treatment of Anemia in Erythropoiesis Stimulating Agent-Naïve Patients with Lower-Risk Myelodysplastic Syndromes at ASH 2023
December 09, 2023
From
Bristol Myers Squibb
Via
Business Wire
Tickers
BMY
LPSN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that LivePerson, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
December 09, 2023
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Tickers
LPSN
Scenic Biotech Announces Positive Preclinical Data for its QPCTL Inhibitor SC-2882 as Potential New Therapeutic Approach for Diffuse Large B-Cell Lymphoma
December 09, 2023
From
Scenic Biotech
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.